dokumentacja CagriSema dla kontroli masy ciaa zostaa zoona do amerykaskiej FDA na podstawie bada REDEFINE 1 i REDEFINE 2
Current understanding is largely based on pharmacovigilance data, clinical trial secondary endpoints, case reports, and small observational studies
A 2023 Cochrane review found that Cerebrolysin provided no clear benefit for preventing death in acute ischemic stroke, and noted a potentially higher rate of spontaneous adverse events in some trial subgroups
Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials
So, Seth, the idea that you could deploy something on a massive scale and only deal with the legal consequences much later is all the more uncertain
Retatrutide has developed one of the most rapidly growing pre-clinical research profiles of any metabolic peptide currently in active study: Pre-clinical metabolic research in obese animal models has reported body weight and fat mass reductions with Retatrutide that exceed those observed with dual-receptor compounds including Tirzepatide at comparable doses and suggesting that the addition of glucagon receptor engagement to combined GLP-1/GIP agonism produces meaningfully greater metabolic effects in experimental settings
